MARKET

MDXG

MDXG

Mimedx Group Inc
NASDAQ
6.31
+0.02
+0.32%
Opening 12:52 04/22 EDT
OPEN
6.34
PREV CLOSE
6.29
HIGH
6.39
LOW
6.25
VOLUME
155.32K
TURNOVER
0
52 WEEK HIGH
9.27
52 WEEK LOW
3.310
MARKET CAP
927.31M
P/E (TTM)
17.36
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MDXG last week (0415-0419)?
Weekly Report · 6h ago
Weekly Report: what happened at MDXG last week (0408-0412)?
Weekly Report · 04/15 09:51
Weekly Report: what happened at MDXG last week (0401-0405)?
Weekly Report · 04/08 09:53
Oversold Conditions For MiMedx Group (MDXG)
NASDAQ · 04/02 16:18
Weekly Report: what happened at MDXG last week (0325-0329)?
Weekly Report · 04/01 09:53
MiMedx Group (MDXG) Receives a Buy from Northland Securities
MiMedx Group has an analyst consensus of Strong Buy, with a price target of $12.25. Northland Securities analyst Carl Byrnes has reiterated a Buy rating on the stock. The company’s shares closed yesterday at $7.61. The stock has a corporate insider sentiment of negative.
TipRanks · 03/28 12:55
Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS)
TipRanks · 03/28 11:50
MiMedx falls as FDA reaffirms position on Axiofill
Seeking Alpha · 03/27 13:09
More
About MDXG
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.

Webull offers MiMedx Group Inc stock information, including NASDAQ: MDXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDXG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDXG stock methods without spending real money on the virtual paper trading platform.